Fig. 3From: Long-term efficacy of crizotinib in a metastatic papillary renal carcinoma with MET amplification: a case report and literature reviewChronological evolution of target lesions assessed by CT scan, with the timeline in Panel (a) and the RECIST 1.1 response evaluation in Panel (b)Back to article page